Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
Cardiovascular Research|October 8, 2019
Colesevelam enhances the beneficial effects of brown fat activation on hyperlipidaemia and atherosclerosis developmentEnchen Zhou, Geerte Hoeke, Zhuang Li, et al.
Cell Metabolism|January 11, 2023
Discovery, development, and clinical proof of mechanism of LY3463251, a long-acting GDF15 receptor agonistOlivier Benichou, Tamer Coskun, Malgorzata D Gonciarz, et al.
Cell Metabolism|April 9, 2025
Tirzepatide did not impact metabolic adaptation in people with obesity, but increased fat oxidationEric Ravussin, Guillermo Sanchez-Delgado, Corby K Martin, et al.
Journal of the Endocrine Society|July 10, 2019
Long-Acting and Selective Oxytocin Peptide Analogs Show Antidiabetic and Antiobesity Effects in Male MiceBrandy Snider, Andrea Geiser, Xiao-Peng Yu, et al.
Plos One|March 29, 2013
Rational design of a fibroblast growth factor 21-based clinical candidate, LY2405319Alexei Kharitonenkov, John M Beals, Radmila Micanovic, et al.
Diabetes|May 2, 2022
GIPR Agonism Inhibits PYY-Induced Nausea-Like BehaviorRicardo J Samms, Richard Cosgrove, Brandy M Snider, et al.
Nature Medicine|June 24, 2025
Tirzepatide on ingestive behavior in adults with overweight or obesity: a randomized 6-week phase 1 trialCorby K Martin, Owen T Carmichael, Susan Carnell, et al.
Pageof 10